Evidence map›Paper›PMID 19025480›Full record

ArticleAIDS patient care and STDs2008

Health-related quality of life in HIV-infected patients: the role of substance use.

P Todd Korthuis, Laurie C Zephyrin, John A Fleishman, Somnath Saha, Joshua S Josephs, Moriah M McGrath, James Hellinger, Kelly A Gebo, HIV Research Network

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07414459 (Combining Social Network Strategies and Routine Substance Use Screening), which is not on this map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07414459 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Combining Social Network Strategies and Routine Substance Use Screening

TypeinterventionalSponsorUniversity of California, San DiegoRan2026 to 2029Enrolled500ConditionsHIV, Substance Use Disorder (SUD)ArmsSubstance use disorder screening, Social network intervention
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Patterns of Health-related Quality of Life in Men Who Inject Drugs: A Survey in Southeast Iran.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Gender Differences in Depression and Quality of Life in Current and Abstinent Ketamine Users.International journal of environmental research and public health · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

P Todd KorthuisDepartment of Medicine, Oregon Health and Science University, Portland, Oregon 97239-3098, USA. korthuis@ohsu.edu
Laurie C Zephyrin
John A Fleishman
Somnath Saha
Joshua S Josephs
Moriah M McGrath
James Hellinger
Kelly A Gebo
HIV Research Network
Johns Hopkins University · USOregon Health & Science University · USAgency for Healthcare Research and Quality · USColumbia University · USCommunity Medical Center · USPortland VA Medical Center · US

Funding

HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICER01DA011602 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 1998 to 2013
$10.8M
MID CAREER INVESTIGATOR AWARDK24DA000432 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2000 to 2009
$1.5M
Alcohol and HIV Treatment and Clinical ProgressionR01AA016893 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2008 to 2011
$1.3M
Quality Outcomes for Patients with Drug Abuse and HIVK23DA019809 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2007 to 2011
$892k
HIV Care for Substance Users with Psychiatric DisordersK23DA019820 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI HIMELHOCH, SETH S · 2005 to 2009
$883k
Alcohol and Psychiatric Comorbidity in HIV+ WomenK23AA015313 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI · 2005 to 2009
$875k
IMPROVING HEALTH CARE UTILIZATION IN HIV+ DRUG USERSK23DA000523 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2001 to 2005
$794k
Alcohol and HIV Progression in the Hopkins HIV CohortR21AA015032 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2004 to 2005
$388k
CLINICAL OUTCOMES IN ELDERLY HIV PATIENTSR01AG026250 · NIA · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2006 to 2007
$197k
NIAAA NIH HHS K23 AA015313NIAAA NIH HHS R01 AA016893NIAAA NIH HHS R21 AA015032NIA NIH HHS R01 AG026250NIDA NIH HHS K23-DA00523NIDA NIH HHS K-23-DA019820NIDA NIH HHS K24 DA000432NIDA NIH HHS R01 DA011602PHS HHS 290-01-0012
6 · The paper itself

Abstract

HIV infection and substance use disorders are chronic diseases with complex contributions to health-related quality of life (HRQOL). We conducted a cross-sectional survey of 951 HIV-infected adults receiving care at 14 HIV Research Network sites in 2003 to estimate associations between HRQOL and specific substance use among HIV-infected patients. HRQOL was assessed by multi-item measures of physical and role functioning, general health, pain, energy, positive affect, anxiety, and depression. Mental and physical summary scales were developed by factor analysis. We used linear regression to estimate adjusted associations between HRQOL and current illicit use of marijuana, analgesics, heroin, amphetamines, cocaine, sedatives, inhalants, hazardous/binge alcohol, and drug use severity. Current illicit drug use was reported by 37% of subjects. Mental HRQOL was reduced for current users [adjusted beta coefficient -9.66, 95% confidence interval [(CI]) -13.4, -5.94] but not former users compared with never users. Amphetamines and sedatives were associated with large decreases in mental (amphetamines: beta = -22.8 [95% CI -33.5, -12.0], sedatives: beta = -18.6 [95% CI -26.2, -11.0]), and physical HRQOL (amphetamines: beta = -11.5 [95% CI -22.6, -0.43], sedatives: beta = -13.2 [95% CI -21.0, -5.36]). All illicit drugs were associated with decreased mental HRQOL: marijuana (beta = -7.72 [95% CI -12.0, -3.48]), non-prescription analgesics (beta = -13.4 [95% CI -20.8, -6.07]), cocaine (beta = -10.5 [95% CI -16.4, -4.67]), and inhalants (beta = -14.0 [95% CI -24.1, -3.83]). Facilitating sobriety for patients with attention to specific illicit drugs represents an important avenue for elevating HRQOL in patients living with HIV.

Indexed as

Quality of LifeAdolescentAdultFemaleHealth StatusHealth SurveysHIV InfectionsHumansIllicit DrugsInterviews as TopicMaleMental HealthMiddle AgedSeverity of Illness IndexSickness Impact ProfileSubstance-Related DisordersIllicit Drugs

Identifiers

PMID19025480
PMCPMC2596984
OpenAlexW1999676148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.